BAB, Inc.
BABB
$0.79
-$0.0255-3.13%
| Weiss Ratings | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B+ | |||
| Rating Factors | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Good | |||
| Growth Index | Fair | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.52 | |||
| Price History | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.47% | |||
| 30-Day Total Return | -7.93% | |||
| 60-Day Total Return | -2.79% | |||
| 90-Day Total Return | 0.04% | |||
| Year to Date Total Return | -4.60% | |||
| 1-Year Total Return | 10.92% | |||
| 2-Year Total Return | 13.53% | |||
| 3-Year Total Return | 9.26% | |||
| 5-Year Total Return | 39.96% | |||
| 52-Week High % Change | -21.59% | |||
| 52-Week Low % Change | 14.55% | |||
| Price | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.04 | |||
| 52-Week Low Price | $0.71 | |||
| 52-Week Low Price (Date) | Dec 31, 2024 | |||
| 52-Week High Price (Date) | Jan 15, 2025 | |||
| Valuation | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.92M | |||
| Enterprise Value | 4.12M | |||
| Price/Earnings (TTM) | 11.26 | |||
| Earnings Per Share (TTM) | 0.07 | |||
| Earnings Per Share Growth | 12.42% | |||
| Price/Earnings To Growth | 0.91 | |||
| Price/Sales (TTM) | 1.67 | |||
| Price/Book (Q) | 1.77 | |||
| Enterprise Value/Revenue (TTM) | 1.16 | |||
| Price | $0.79 | |||
| Enterprise Value/EBITDA (TTM) | 6.05 | |||
| Enterprise Value/EBIT | 6.09 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 7.26M | |||
| Dividend Yield | 4.90% | |||
| Div. Per Share (Most Recent) | $0.01 | |||
| Dividend Per Share (TTM) | $0.04 | |||
| Payout Ratio (TTM) | 69.15% | |||
| Dividend Per Share (Most Recent) | $0.01 | |||
| Company Info | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 847 948 7520 | |||
| Address | 500 Lake Cook Road Deerfield, IL 60015 | |||
| Website | www.babcorp.com | |||
| Country | United States | |||
| Year Founded | 1993 | |||
| Profitability | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 19.09% | |||
| Profit Margin | 14.81% | |||
| Management Effectiveness | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 9.26% | |||
| Return on Equity | 16.11% | |||
| Income Statement | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.55M | |||
| Total Revenue (TTM) | 3.55M | |||
| Revenue Per Share | $0.49 | |||
| Gross Profit (TTM) | 2.37M | |||
| EBITDA (TTM) | 681.10K | |||
| EBIT (TTM) | 677.00K | |||
| Net Income (TTM) | 525.20K | |||
| Net Income Avl. to Common (TTM) | 525.20K | |||
| Total Revenue Growth (Q YOY) | -0.91% | |||
| Earnings Growth (Q YOY) | -12.35% | |||
| EPS Diluted (TTM) | 0.07 | |||
| EPS Diluted Growth (Q YOY) | -12.63% | |||
| Balance Sheet | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.18M | |||
| Cash Per Share (Q) | $0.30 | |||
| Total Current Assets (Q) | 2.51M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 3.34M | |||
| Current Ratio (Q) | 3.461 | |||
| Book Value Per Share (Q) | $0.46 | |||
| Total Assets (Q) | 4.84M | |||
| Total Current Liabilities (Q) | 725.10K | |||
| Total Debt (Q) | 378.10K | |||
| Total Liabilities (Q) | 1.50M | |||
| Total Common Equity (Q) | 3.34M | |||
| Cash Flow | BABB - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -10.00K | |||
| Cash from Financing (TTM) | -363.10K | |||
| Net Change in Cash (TTM) | 264.70K | |||
| Levered Free Cash Flow (TTM) | 536.30K | |||
| Cash from Operations (TTM) | 637.70K | |||
